Literature DB >> 21118014

Leishmaniasis in a dog native to Colorado.

Kate S Freeman1, Matthew D Miller, Edward B Breitschwerdt, Michael R Lappin.   

Abstract

CASE DESCRIPTION: A 1-year-old 32.5-kg (71.5-lb) sexually intact male foxhound-Treeing Walker Coonhound cross was evaluated because of a 2.5-month history of dermatologic lesions, weight loss, and diarrhea. CLINICAL
FINDINGS: Physical examination revealed muscle wasting, lymphadenopathy, and multifocal pruritic dermatologic lesions of alopecia, thickening, erythema, and follicular casting. Hematologic and serum biochemical analyses revealed nonregenerative anemia, mono-cytosis, hypercalcemia, hyperproteinemia, and hyperglobulinemia. Proteinuria was identified on urinalysis. Hepatomegaly, splenomegaly, and diffuse abdominal lymphadenomegaly were detected on abdominal ultrasonography. A diagnosis of leishmaniasis was confirmed by ELISA detection of serum antibodies against Leishmania spp, a high serum indirect fluorescent antibody titer (1:1,024) against Leishmania infantum, amplification of Leishmania DNA on PCR assay of a whole blood sample and a lymph node aspirate, and histologic identification of suspected Leishmania amastigotes in skin specimens. In addition, the dog had a low CD4+:CD8+ lymphocyte ratio of 1:1. TREATMENT AND OUTCOME: The dog was euthanized because of the severity of leishmaniasis and poor prognosis. This dog was from a litter of 10 puppies that included 4 stillborn puppies, 2 puppies that died as neonates, and 1 littermate that was euthanized at 1 year of age because of a high serum antibody titer against Leishmania spp. Eventually the foxhound dam was euthanized because of a high serum antibody titer against Leishmania spp. The dog had been raised with an unaffected littermate, its sire, and an unrelated Treeing Walker Coonhound female that were seronegative for Leishmania infection. CLINICAL RELEVANCE: Although vertical disease transmission was suspected, it is possible that L infantum is now endemic in Colorado. Leishmaniasis should be considered in dogs with scaly dermatoses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118014     DOI: 10.2460/javma.237.11.1288

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

Review 1.  Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.

Authors:  Bruno Mendes Roatt; Rodrigo Dian de Oliveira Aguiar-Soares; Wendel Coura-Vital; Henrique Gama Ker; Nádia das Dores Moreira; Juliana Vitoriano-Souza; Rodolfo Cordeiro Giunchetti; Cláudia Martins Carneiro; Alexandre Barbosa Reis
Journal:  Front Immunol       Date:  2014-06-13       Impact factor: 7.561

Review 2.  Canine Leishmaniasis: An Overview of the Current Status and Strategies for Control.

Authors:  Raul Rio Ribeiro; Marilene Suzan Marques Michalick; Manoel Eduardo da Silva; Cristiano Cheim Peixoto Dos Santos; Frédéric Jean Georges Frézard; Sydnei Magno da Silva
Journal:  Biomed Res Int       Date:  2018-03-29       Impact factor: 3.411

3.  Biological implant-associated granulomatous inflammation resulting in secondary hypercalcemia and azotemia in a dog.

Authors:  Ken J Linde; Taylor R Kelleher; James A Perry
Journal:  Clin Case Rep       Date:  2018-07-25

4.  Demographics and travel history of imported and autochthonous cases of leishmaniosis in dogs in the United States and Canada, 2006 to 2019.

Authors:  Taylor Estes Gin; Erin Lashnits; James M Wilson; Edward B Breitschwerdt; Barbara Qurollo
Journal:  J Vet Intern Med       Date:  2021-02-26       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.